Bioanalysis and Metabolomics, 2nd Edition
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmacokinetics and Pharmacodynamics".
Deadline for manuscript submissions: closed (20 May 2024) | Viewed by 9899
Special Issue Editors
Interests: drug metabolism; metabolomics; lipidomics
Special Issues, Collections and Topics in MDPI journals
Interests: bioanalysis; drug metabolism; pharmacokinetics; drug interactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recently, techniques for analyzing endogenous and exogenous substances present in biological samples have been developed due to the development of analytical instruments that combine chromatography and mass spectrometry. As a result, as micro-analysis of drugs is possible, microdosing methods for studying the pharmacokinetics of drugs in humans through the administration of sub-therapeutic doses have been developed and applied in clinical trials. In addition, metabolomics techniques that target endogenous substances in biological samples have been developed, and various studies on biomarkers that can be used to diagnose the disease early and evaluate the efficacy of drugs have been actively conducted. This Special Issue aims to highlight current progress in bioanalysis related to drug metabolism and pharmacokinetics and drug- and disease-related metabolomics.
Prof. Dr. Kwang-Hyeon Liu
Prof. Dr. Hye Suk Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioanalysis
- method validation
- pharmacokinetics
- metabolomics
- lipidomics
- biomarkers
- mass spectrometry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Related Special Issue
- Bioanalysis and Metabolomics in Pharmaceutics (8 articles)